Eski Bir Tartışmanın Sonu: Metilentetrahidrofolat Redüktaz Gen Polimorfizmleri Tromboz Riskini Artırmamaktadır

Kaynakça (4)

1. Ozturk N, Bakan E, Gul MA, Bakan N, Sebin E, Kiziltunc A. the frequency of some thrombophilic mutations in eastern Turkey. Eurasian J Med 2016
2. [CrossRef] 2. Simone B, De Stefano V, Leoncini E, et al. Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls. Eur J Epidemiol 2013
3. [CrossRef] 3. Karki R, Pandya D, Elston RC, Ferlini C. Defining “mutation” and “polymorphism” in the era of personal genomics. BMC Med Genomics 2015
4. [CrossRef] 4. International Committee of Medical Journal Editors. Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly work in Medical Journals: 2015 [updated December 2015]. Available at: URL: http://www.icmje.org